» Authors » Xavier Iriart

Xavier Iriart

Explore the profile of Xavier Iriart including associated specialties, affiliations and a list of published articles. Areas
Snapshot
Articles 161
Citations 1708
Followers 0
Related Specialties
Top 10 Co-Authors
Published In
Affiliations
Soon will be listed here.
Recent Articles
1.
Rocchi S, Scherer E, White P, Guitton A, Alanio A, Botterel F, et al.
J Clin Microbiol . 2025 Jan; 63(2):e0152524. PMID: 39745482
Importance: Mucormycosis is a life-threatening mold infection affecting immunosuppressed patients but also other patients with diabetes or trauma. Better survival is linked to shorter delays in diagnosis and treatment initiation....
2.
Garrouste C, Poirier P, Uro-Coste C, Iriart X, Kamar N, Bonhomme J, et al.
Transpl Int . 2024 Dec; 37:13518. PMID: 39726674
Trial Registration Number: ClinicalTrials.gov ID: NCT05417815.
3.
Silini A, Iriart X
Int J Cardiol Congenit Heart Dis . 2024 Dec; 8:100370. PMID: 39712051
Percutaneous edge-to-edge repair has become a valid technique for symptomatic mitral and tricuspid regurgitation in patients with acquired cardiopathies deemed ineligible for surgery. In congenital heart disease (CHD) and more...
4.
Millon L, Botterel F, Bonhomme J, Valot S, Poirier P, Durieux M, et al.
J Mycol Med . 2024 Nov; 34(4):101520. PMID: 39577076
This study investigates the diagnostic practices for mucormycosis among 30 French University Hospital mycology laboratories, in 2024. All laboratories perform both direct examination and culture, with fluorescent brighteners being the...
5.
Garot P, Gall E, Zendjebil S, Cepas-Guillen P, Iriart X, Farah B, et al.
Int J Cardiol . 2024 Oct; 418:132614. PMID: 39395724
Background: Patient-specific 3-dimensional (3D) computational modelling offers a tailored approach with promising results, but experience using digital-twin fusion on real-time fluoroscopy to guide left atrial appendage closure (LAAC) is unreported....
6.
Albors C, Mill J, Olivares A, Iriart X, Cochet H, Camara O
PLoS Comput Biol . 2024 Sep; 20(9):e1011546. PMID: 39325818
Left atrial appendage occlusion devices (LAAO) are a feasible alternative for non-valvular atrial fibrillation (AF) patients at high risk of thromboembolic stroke and contraindication to antithrombotic therapies. However, optimal LAAO...
7.
Hauguel-Moreau M, Guedeney P, Dauphin C, Auffret V, Clerc J, Marijon E, et al.
Circulation . 2024 Sep; 150(21):1659-1668. PMID: 39222035
Background: The real incidence of atrial arrhythmia (AA) after patent foramen ovale (PFO) closure and whether this complication can be prevented remain unknown. We assessed whether flecainide is effective to...
8.
Korsholm K, Iriart X, Saw J, Wang D, Berti S, Galea R, et al.
JACC Cardiovasc Interv . 2024 Aug; 17(15):1747-1764. PMID: 39142755
Left atrial appendage occlusion (LAAO) is rapidly growing as valid stroke prevention therapy in atrial fibrillation. Cardiac imaging plays an instrumental role in preprocedural planning, procedural execution, and postprocedural follow-up....
9.
Tchamwa Bamini G, Charpentier E, Guemas E, Chauvin P, Fillaux J, Valentin A, et al.
Parasite . 2024 Jul; 31:40. PMID: 39052010
Dientamoeba fragilis is a ubiquitous intestinal parasite with detection in the stools that has become increasingly frequent following the advent of PCR as a routine screening tool. However, the pathogenicity...
10.
Saw J, Vij V, Galea R, Piayda K, Nelles D, Vogt L, et al.
Echocardiography . 2024 Jul; 41(8):e15888. PMID: 39042643
Background: Device-related thrombosis (DRT) is a common finding after left atrial appendage closure (LAAC) and is associated with worse outcomes. As women are underrepresented in clinical studies, further understanding of...